Palliation of recurrent myxofibrosarcoma with radiotherapy and hyperthermia
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2010-11-01 / Singapore Med J 2010 Nov;51(11):e187-90[WT1 peptide pulsed dendritic cell therapy with activated T lymphocytes therapy for advanced cancers]
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2240-2Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-11-01 / Int. J. Oncol. 2010 Nov;37(5):1203-17Use of attenuated paramyxoviruses for cancer therapy
/in International Publications, Newcastle Disease Virus /von 2010-11-01 / Expert Rev Vaccines 2010 Nov;9(11):1275-302RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-11-01 / Neoplasia 2010 Nov;12(11):906-14[Multidisciplinary therapy for 984 cancer patients–hyperthermic immunotherapy]
/in Hyperthermia, International Publications /von 2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2243-5The role of hyperthermia in the battle against cancer
/in Hyperthermia, International Publications /von 2010-11-01 / Tumori 2010 Nov-Dec;96(6):902-10Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
/in Dendritic Cells, International Publications /von 2010-11-01 / Expert Opin Biol Ther 2010 Nov;10(11):1539-53
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de